Inspire Medical Systems, Inc. to Report Second Quarter 2021 Financial Results on August 3, 2021

Inspire Medical Systems (NYSE: INSP) will release its Q2 2021 financial results on August 3, 2021, after market close.

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) will release its Q2 2021 financial results on August 3, 2021, after market close. A conference call is scheduled for 5:00 p.m. ET to discuss the results and recent developments. Inspire specializes in innovative, minimally invasive treatments for obstructive sleep apnea. Its Inspire therapy is the first FDA-approved neurostimulation technology for this condition, offering effective treatment options for patients. For more information, visit www.inspiresleep.com.

Positive

• Inspire therapy is the first FDA-approved neurostimulation technology for obstructive sleep apnea.
• The upcoming Q2 2021 results call indicates ongoing investor engagement and transparency.

Negative

• None.

Argus Session date unavailable

-7.60% session move Open Argus

Details

News Market Reaction – INSP

The recorded move for INSP in the trading session of this news was -7.60%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, July 06, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the second quarter 2021 after the close of trading on Tuesday, August 3. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, August 3rd @ 5:00 p.m. Eastern Time:
Domestic:	877-407-0792
International:	201-689-8263
Conference ID:	13720720
Webcast:	http://public.viavid.com/index.php?id=145351

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Inspire Medical Systems release its Q2 2021 financial results?

Inspire Medical Systems will release its Q2 2021 financial results on August 3, 2021, after market close.

What time is the Inspire Medical Systems conference call for the Q2 2021 financial results?

The conference call for the Q2 2021 financial results will begin at 5:00 p.m. Eastern Time on August 3, 2021.

Where can I find more information about Inspire Medical Systems?

More information about Inspire Medical Systems can be found on their official website at www.inspiresleep.com.

What is Inspire Medical Systems known for?

Inspire Medical Systems is known for developing and commercializing innovative solutions for obstructive sleep apnea, including the FDA-approved Inspire therapy.